1. Effect of Potassium Infusions on Serum Levels in Children during Treatment of Diabetic Ketoacidosis
- Author
-
Ryan Majcina, Kimberly Powell, Rawan Musaitif, Sangita Basnet, Randall Robbs, Aayush Khanal, and Giovanna Caprirolo
- Subjects
Pediatric intensive care unit ,medicine.medical_specialty ,endocrine system diseases ,Diabetic ketoacidosis ,business.industry ,Potassium ,nutritional and metabolic diseases ,chemistry.chemical_element ,030208 emergency & critical care medicine ,Retrospective cohort study ,Critical Care and Intensive Care Medicine ,medicine.disease ,Gastroenterology ,Treatment period ,03 medical and health sciences ,0302 clinical medicine ,chemistry ,Interquartile range ,030225 pediatrics ,Internal medicine ,Pediatrics, Perinatology and Child Health ,medicine ,business - Abstract
A retrospective study was done to determine the effect of potassium (K+) infusions on serum levels in children admitted to the pediatric intensive care unit (PICU) with diabetic ketoacidosis (DKA). Eighty-two percent of 92 cases studied received 40 mEq/L K+ infusion over the treatment period of median 13.0 (interquartile range [IQR]: 7–18) hours. The median K+ value at the end of this period was 3.9 (IQR: 3.4–4.2) mEq/L. There were 31 data points of low K+ values (5.5 mEq/L) during this treatment period. The K+ infusions of 40 mEq/L may be sufficient to normalize serum K+ when treating DKA.
- Published
- 2020